BioTime, Inc.
1301 Harbor Bay Parkway
Suite 100
Alameda,
CA 94502
United States - Map
Phone: 510-521-3390
Fax: 510-521-3389
Web Site: http://www.biotimeinc.com
| BioTime, Inc., a biotechnology company, develops blood plasma volume expanders and blood replacement solutions for hypothermic (low temperature) surgery, and organ preservation solutions and technology for use in surgery, emergency trauma treatment, and other applications. The company, through its subsidiary, Embryome Sciences, Inc., engages in the research and development of embryonic stem cell technology and products for use in regenerative medicine. Its stem cell technologies comprise iPS technology that allows the transformation of human cells of the body back to a primordial stem cell state; and ACTCellerate technology that permits the generation of purified cells of the human body. The companys lead product, Hextend, is a hetastarch-based synthetic blood plasma volume expander used in surgery, emergency trauma treatment, and other applications. It manufactures and distributes Hextend in the United States by Hospira, Inc. and in South Korea by CJ CheilJedang Corp. under licensing agreements. The companys products under development include PentaLyte, a pentastarch-based synthetic plasma expander for the treatment of hypovolemia in cardiac surgery; HetaCool, a plasma volume expander to facilitate the cooling of a patients body and maintaining body temperatures; and HetaFreeze and other freeze-protective solutions. Its stem cell products comprise ESpan cell growth media for the growth of human embryonic progenitor cells; progenitor cell types made using the ACTCellerate technology; and human embryonic stem cell lines carrying inherited genetic diseases. The company is also developing ESpy cell lines that are derivatives of hES cells; new growth and differentiation factors to manufacture specific cell types from embryonic stem cells; and purification tools to researchers in quality control of products for regenerative medicine. The company was founded in 1990 and is headquartered in Alameda, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Michael D. West Ph.D., 55
Chief Exec. Officer |
$
250.00K | N/A | Mr. Robert W. Peabody C.P.A., 55
Chief Operating Officer and Sr. VP |
$
160.00K | N/A | Mr. Steven A. Seinberg J.D., 42
Chief Financial Officer, Principal Accounting Officer and Treasurer |
N/A
| N/A | Ms. Judith Segall , 56
VP of Admin., Corp. Sec. |
N/A
| N/A | Dr. Hal Sternberg Ph.D., 56
VP of Research |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.27% Nasdaq 0.00%
Profile
